Urogen Pharma Ltd.
SEC CIK 1668243 · URGN · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Butitta Cynthia M | Director | filed 2019 - 2026 |
| Belldegrun Arie | Director | filed 2019 - 2026 |
| Robinson James A. Jr. | Director | filed 2023 - 2026 |
| Holden Stuart | Director | filed 2019 - 2026 |
| WEN Leana | Director | filed 2022 - 2026 |
| Wildman Daniel George | Director | filed 2022 - 2026 |
| Cohen Fred E | Director | filed 2019 - 2024 |
| Nussbaum Ran | Director | filed 2019 - 2023 |
| Falberg Kathryn E | Director | filed 2019 - 2021 |
| Tomasello Shawn | Director | filed 2019 - 2021 |
| Bentsur RON | Director · Chief Executive Officer | filed 2019 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Schoenberg Mark | Chief Medical Officer | filed 2019 - 2026 |
| Barrett Elizabeth A. | Chief Executive Officer | filed 2019 - 2026 |
| Smith Jason Drew | General Counsel | filed 2020 - 2026 |
| Degnan Chris | Chief Financial Officer | filed 2024 - 2026 |
| Kim Dong | Chief Financial Officer | filed 2022 - 2024 |
| Henderson Molly | Chief Financial Officer | filed 2020 - 2022 |
| Pfreundschuh Peter P. | Chief Financial Officer | filed 2019 - 2020 |
| Mullennix Stephen | Chief Operating Officer | filed 2019 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.